Infection control within Intensive Care Units (ICUs) and Neonatal Intensive Care Units (NICUs) is a matter of life and death. These environments house the most vulnerable patients whose immune systems are either severely compromised or underdeveloped.
While hospitals employ multiple strategies to prevent the spread of infections, one crucial tool often underutilized is temperature screening for healthcare workers. Identifying contagious employees before they display symptoms is a proactive measure that can significantly enhance infection control, safeguarding patients and healthcare providers.
The High Stakes of Infection Control in ICUs and NICUs
The High Stakes of Infection Control in ICUs and NICUs
ICUs and NICUs provide critical care to patients who are at the highest risk of severe complications from infections. For these patients, even a minor illness can escalate quickly into a life-threatening situation.
Newborns in NICUs, for example, often have underdeveloped immune systems, making them particularly susceptible to infections. Similarly, ICU patients may be immunocompromised due to their underlying conditions or the treatments they are receiving.
In these settings, the introduction of any pathogen can have dire consequences. Hospital-acquired infections (HAIs) remain a significant concern, with studies showing that these infections can lead to extended hospital stays, increased healthcare costs, and, in severe cases, death. Preventing HAIs is, therefore, a top priority, and it starts with ensuring that the healthcare workers themselves are not the source of the infection.
The Role of Healthcare Workers in Infection Spread
Healthcare workers are the backbone of ICUs and NICUs, but they also represent a potential source of infection. The nature of their work—caring for multiple patients, performing invasive procedures, and working long hours—means they are at constant risk of both contracting and spreading infections. Staff working sick (presenteeism) exacerbates the risk.
Presenteeism is particularly dangerous in high-risk environments like ICUs and NICUs because employees may unknowingly transmit infections to vulnerable patients.
While essential, traditional methods of infection control, such as hand hygiene and the use of personal protective equipment (PPE), are not foolproof. They rely on consistent, correct usage and do not address the risk posed by asymptomatic but contagious healthcare workers.
Temperature Screening as a Proactive Measure
The New Wello Protocol with Wello AI paired with the FDA-cleared Class II clinical temperature screening welloStationXTM is a simple, effective solution to this challenge.
Hospitals can identify contagious personnel before their shifts; early intervention, such as requiring facial masks or maybe sending the employee home, significantly lowers the chance of infection spread within the hospital.
Temperature screening does not replace other infection control measures. It serves as an additional layer of protection. A healthcare worker with a mild fever might dismiss it as fatigue or stress, but temperature screening can catch it before they can infect others.
The Impact on Patient Outcomes and Staff Health
Implementing temperature screening in ICUs and NICUs can profoundly impact patient outcomes. By preventing the introduction of infectious agents into these sensitive environments, hospitals can reduce the incidence of HAIs, leading to shorter hospital stays, lower healthcare costs, and, most importantly, improved survival rates for critically ill patients.
Moreover, temperature screening also benefits the healthcare workers themselves. Early identification of illness allows them to seek treatment sooner, reducing the severity and duration of their illness. It also reduces the likelihood of burnout, as sick employees are not pushing themselves to work through their illness, which can exacerbate their condition and the risk to patients.
A Necessary Investment in Safety
Temperature screening is a critical tool for infection control in ICUs and NICUs. By identifying contagious employees before they show symptoms, hospitals can significantly reduce the risk of infection, protecting patients and staff. In these high-stakes environments, where the cost of an infection can be life-threatening, the proactive use of temperature screening is not just beneficial—it is essential.
Investing in technologies like the New Wello Protocol with Wello AI and FDA-cleared Class II clinical temperature screening welloStationXTM is an investment in safety and ethical care.
You’re delivering the best possible care to vulnerable patients while proactively reducing the added risk of hospital-acquired infections.
If you’re managing disease spread in the workplace based on symptoms, it’s too late. People are contagious whether or not they appear ill. Don't let one sick employee infect ten more. Minimize disease spread with the New Wello Protocol from Wello AI.
Reduce Expensive Workplace Illness